Psychedelic Stocks Archives - Page 55 of 61

WednesdayMar 23, 2022 3:38 pm

Colorado Psychedelics Activists Unite Behind November Ballot Measure

Activists in Colorado have decided to proceed with a single proposal to legalize psilocybin. This proposal, which is one of the quartet of psychedelic reform ballot measures drafted and filed for this year's ballot, will also offer a pathway for the sealing of prior conviction records and establish healing centers where individuals can use psilocybin for therapeutic purposes. The measure, known as Initiative 58, would also allow regulators to decide whether to legalize mescaline, ibogaine and DMT. Veronica Perez and Kevin Matthews, who managed the campaign behind Denver’s historic vote to locally decriminalize psilocybin in 2019, are the brains behind…

TuesdayMar 22, 2022 2:17 pm

Washington State Lawmakers Allocate $200K to Psilocybin Research

Last week, legislators in Washington State advanced a budget measure to the state’s governor. This measure includes a proposal to allocate $200,000 in funding to be used to support the Psilocybin Wellness Workgroup to study the possible legalization of psilocybin services in the state. If the bill is approved by Gov. Jay Inslee, the workgroup will be tasked with compiling a report on psilocybin services opportunities and wellness as stated in the 2023 fiscal year budget proposal. Most of the focus on the psilocybin section will center on analysis and potential improvements that can be made to a Senate measure,…

MondayMar 21, 2022 12:52 pm

Following the Ukraine War on Social Media May Negatively Impact Mental Health

We recently saw Russia invade Ukraine, which prompted millions of Ukrainians to flee their homes as the war intensified. Disturbing videos and photos of the damage done to buildings and people in cities such as Kharkov and Kyiv can be accessed online, even by those thousands of miles away. With many watching the crisis unfold through the standard news sources as well as on social media applications such as Instagram and TikTok, checking for updates isn’t hard to do. However, research has found that coverage of traumatic events on the news can negatively affect the mental health of viewers. Professor…

FridayMar 18, 2022 3:46 pm

Psychedelics Industry Sees Huge Interest from Pharmaceutical Sector Players

Various companies and experts are hailing psychedelics such as MDMA, LSD and psilocybin, as well as mind-altering substances such as ketamine, as the next revolutionary treatment for a number of mental health conditions. The surge in the popularity of psychedelic substances started almost a decade ago, with different research groups at the University of Zurich, Imperial College London, New York University, Johns Hopkins University and the University of California discovering the rapid and lasting effects of using psychedelics, including psilocybin, to treat small groups of individuals with existential distress and treatment-resistant depression. The results from these studies broke the model…

ThursdayMar 17, 2022 1:11 pm

Study Suggests That MDMA Therapy for PTSD May Save Millions in Healthcare Costs

A new study has found that MDMA-assisted therapy may extend and improve the lives of patients suffering from severe and chronic PTSD and also decrease the cost of healthcare. MDMA is a drug known to alter an individual’s mood and perception; it is commonly referred to as molly or ecstasy. Elliot Marseille, the study’s corresponding author, stated that he launched the Global Initiative for Psychedelic Science Economics together with his colleagues from UC Berkeley and UCSF after seeing encouraging results on psychedelic-assisted therapy from different clinical trials. Marseille, who is also the founder of Health Strategies International, explained that the…

WednesdayMar 16, 2022 12:55 pm

Study Finds Psilocybin Microdosing Doesn’t Decrease Anxiety, Depression Symptoms

Various studies have found that regular psilocybin doses have long lasting and profound effects on an individual’s mood and personality. However, a new placebo-controlled study has discovered that consuming microdoses of psilocybin at regular intervals doesn’t improve symptoms of anxiety or depression. The study’s findings, which were reported in the “Journal of Psychopharmacology,” challenge claims that microdosing on psychedelics improves mental health. Preliminary studies have shown that microdosing psychedelics is linked to a range of psychological benefits, including decreased stress and increased productivity. However, most of the studies done on microdosing had limitations, the main one being a lack of…

TuesdayMar 15, 2022 1:56 pm

Giving Zebrafish Microdoses of LSD Reveals Therapeutic Potential

Zebrafish share about 70% of the same genes with humans and roughly 85% of human genes known to be linked to human diseases. This makes them a unique model animal for biomedical research, in addition to being social, which makes them suitable for behavioral research into drug discovery and psychiatric disorders. Researchers conducting studies on LSD are microdosing zebrafish in an effort to explore potential new treatments for alcohol use disorder and mental illness. Microdosing refers to ingesting small amounts of a psychedelic. It is believed that microdosing improves open-mindedness, sparks creativity and increases productivity. For their study, the researchers…

MondayMar 14, 2022 11:24 am

Missouri Legislator Files Measure to Decriminalize Psychedelics

Last week, a Missouri legislator filed a measure that would legalize an extensive range of psychedelic drugs for therapeutic use and decriminalize low-level possession in the state. The measure was sponsored by Republican lawmaker, Rep. Tony Lovasco. It is the latest example of psychedelic reforms being introduced in states that are traditionally conservative. The measure would provide patients suffering from conditions such as post-traumatic stress disorder treatment-resistant depression and other terminal illnesses with access to a wider range of substances including ibogaine, mescaline, DMT and psilocybin in a clinical setting. Patients will be allowed to access this treatment option at…

FridayMar 11, 2022 2:06 pm

Research Finds That Psilocybin Mushrooms May Help Treat Severe Depression

Psilocybin has been used for millennia around the globe for many uses, including for spiritual connections as well as a remedy in some Indigenous communities. Research has shown that this hallucinogenic compound found in “magic mushrooms” can be used to treat severe depression. However, since it was banned in 1970, psilocybin remains classified as a Schedule I substance under the Controlled Substances Act. Substances under this classification are considered to have a high potential for abuse with no accepted medical use. This isn’t the case for most substances under this classification, and as more research on psychedelics surfaces, this may…

ThursdayMar 10, 2022 12:07 pm

Psychedelics May Help Individuals with Eating Disorders

Negative body image usually causes anxiety and depression, and in most people, it can also cause eating disorders and body dysmorphia to develop. Figures from the National Association of Anorexia Nervosa and Associated Disorders show that about 9% of the global population suffers from eating disorders. These conditions mainly affect women, many of whom have shared how psychedelics have helped them manage body dysmorphia, dissatisfaction and the stress, depression and anxiety that accompanies this cycle. Body dysmorphia is a psychological disorder that causes an individual to imagine imperfections or overvalue minute imperfections by being excessively concerned with their bodies. While…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks